Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fenfluramine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 95,617Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FINTEPLA® (Fenfluramine) Results On Managing Seizures Published In Epilepsia
    FINTEPLA® (Fenfluramine) Results On Managing Seizures Published In Epilepsia

    24 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fintepla-fenfluramine-results-examining-its-impact-in-managing-generalized-tonic-clonic-seizures-in-developmental-and-epileptic-encephalopathies-published-in-epilepsia-302179742.html

    PR NEWSWIRE
    24 Jun 2024
    Share Share
    UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project
    UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project

    20 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617167454/en

    BUSINESSWIRE
    20 Jun 2024
    Share Share
    Acino completes acquisition of M8 Pharmaceuticals
    Acino completes acquisition of M8 Pharmaceuticals

    04 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/04/2789958/0/en/Acino-completes-acquisition-of-M8-Pharmaceuticals-significantly-expanding-presence-and-capabilities-in-Latin-America.html

    GLOBENEWSWIRE
    04 Dec 2023
    Share Share
    UCB presents new data about the real-world experience of FINTEPLA
    UCB presents new data about the real-world experience of FINTEPLA

    02 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ucb-presents-new-data-about-the-real-world-experience-of-fintepla-fenfluramine-and-rare-epilepsy-syndromes-at-2023-american-epilepsy-society-aes-annual-meeting-302002158.html

    PR NEWSWIRE
    02 Dec 2023
    Share Share
    UCB Announces FINTEPLA® (fenfluramine) Oral Solution
    UCB Announces FINTEPLA® (fenfluramine) Oral Solution

    17 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ucb-announces-fintepla-fenfluramine-oral-solution-is-now-descheduled-and-is-no-longer-listed-as-a-controlled-substance-301798777.html

    PR NEWSWIRE
    17 Apr 2023
    Share Share
    CHMP recommends fenfluramine for LGS-associated seizures
    CHMP recommends fenfluramine for LGS-associated seizures

    20 Dec 2022

    // EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/177782/chmp-recommends-fenfluramine-for-lgs-associated-seizures/

    EUROPEANPHARMACEUTICALREVIEW
    20 Dec 2022
    Share Share